Apriso Sponsored Research Reveals Quality by Execution is Just as Critical as Quality by Design

Research confirms that Medical Device manufacturers with more capable process design and execution can outperform their peers
Spread the Word
Listed Under

Quality by Execution
Quality By Design
Medical Device
Root-cause Analysis
Regulatory Compliance


Long Beach - California - US

Sept. 5, 2012 - PRLog -- LONG BEACH, CA — September 5, 2012 — Apriso, a leading provider of manufacturing software solutions, today announced findings from a Cambashi research study. The study addressed the common challenges faced when medical device manufacturers seek to expand market share, quality and financial performance in the face of complex, dynamic regulatory environments. Those firms capable of confidently designing and executing their quality and other operational processes fared better, resulting in greater profits, efficiency and operational performance.

The report identified that the industry leaders or “Advancers” (top 25%) are able to increase product complexity, volume, quality and profits – all at the same time. One of the key differentiators that separate the leaders from the rest is their process capability. Specifically, leaders define and execute production processes with superb precision. See the chart at right. For example, when examining a root cause analysis to determine why an out-of-conformance quality event occurred, industry leaders focus more effort on improving the process rather than trying to ascertain if the right processes were simply not executed properly.

In connection with the survey, Dave Empey, Director of Regulatory and Compliance at Zynex Medical, Inc., explained further: “With complaints, are you really getting to root cause, or just writing things up in a file in case the FDA shows up? There is a difference. If you are really trying to get to root cause and find out what you can do on the preventive side, it takes more time on the front end, but saves you pain and money down the road too.”

The report, sponsored by Apriso, focuses on the challenges medical device manufacturers face when seeking to grow, increase quality and improve financial performance in the face of complex, dynamic regulatory environments.

Key Findings:
* Industry leaders (to 25% performers) are increasing product complexity, volume, quality and profits at the same time, attributable in part by defining and executing production processes with superb execution
* A majority of the respondents anticipate launching at least 10 percent more new product introductions over the next three years; 24 percent of the respondents anticipate an increase of greater than 20 percent
* Industry leaders’ reliance upon IT systems interoperability is directly related to their success; better process integration across functions and plants leads to greater agility, quality, efficiency and profits
* While Quality by Design (QbD) is a great start, the benefits can’t be fully realized unless design is accompanied by what can be best referred to as “Quality by Execution;” the most efficient way to execute a Quality process is on an end-to-end basis, across IT systems, locations and functions

Rick Gallisa, Life Sciences Industry Director of Apriso, commented: “Medical device manufacturers are constantly challenged to design and manufacture innovative new products to remain viable. Product life cycles have shortened, global competition has intensified and greater regulatory oversight has put enormous pressure on operational efficiency.” Added Gallisa, “As the Cambashi research indicates, it is critical for medical device manufacturers to improve process and systems interoperability across all manufacturing operations and take a centralized approach to the global manufacturing process in order to best meet these significant challenges.”

Survey Methodology and Availability
The research for this study was conducted during the first half of 2012 and is based on 123 responses from medical device manufacturers. That survey was accompanied by a small set of telephone interviews. A copy of the research study is available free of charge on the Apriso website.

About Apriso Corporation
Apriso is a software company dedicated to helping its customers transform the performance of their global manufacturing operations. It does so by enabling manufacturers to achieve and sustain manufacturing excellence while adapting quickly to market changes. FlexNet, Apriso's manufacturing software, uniquely enables companies to manage processes and share best practices across their operations with its BPM platform-based architecture. Apriso supports continuous improvement initiatives by delivering visibility into, control over and synchronization across manufacturing and the product supply network. Apriso serves nearly 200 customers in 40+ countries across the Americas, Europe, Asia and Africa. Medical Device customers include Stryker Spine, Trixell, Becton Dickinson, Terumo Medical and Johnson & Johnson. Learn more at: http://www.apriso.com. Visit our blog at http://www.apriso.com/blog.

Apriso and FlexNet are registered trademarks of Apriso Corporation. All other trademarks and registered trademarks are the property of their respective owners.
Source:Apriso Corporation
Email:***@apriso.com Email Verified
Tags:Quality by Execution, Quality By Design, Medical Device, Root-cause Analysis, Regulatory Compliance
Location:Long Beach - California - United States
Account Email Address Verified     Account Phone Number Verified     Disclaimer     Report Abuse
Dassault Systèmes PRs
Trending News
Top Daily News
Top Weekly News

Like PRLog?
Click to Share